Emmanuel Bachy, MD, PhD, highlighted high efficacy, durable responses, and a favorable adverse effect profile in follicular lymphoma with high tumor burden.
Emmanuel Bachy, MD, PhD
Advertisement
Articles by Emmanuel Bachy, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM
2
Belantamab Mafodotin Regimen Yields Enduring Responses in NDMM
3
Arlo-Cel Produces Deep Responses in Pretreated R/R Multiple Myeloma
4
Brentuximab Vedotin/Chemo Regimens Show Similar Efficacy in 2L Lymphoma
5